1. Laun, Alyssa S, Shrader, Sarah H, Brown, Kevin J, Song, Zhao-Hui. 2018. GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol. In Acta pharmacologica Sinica, 40, 300-308. doi:10.1038/s41401-018-0031-9. https://pubmed.ncbi.nlm.nih.gov/29941868/
2. Isawi, Israa H, Morales, Paula, Sotudeh, Noori, Lynch, Diane L, Reggio, Patricia H. 2020. GPR6 Structural Insights: Homology Model Construction and Docking Studies. In Molecules (Basel, Switzerland), 25, . doi:10.3390/molecules25030725. https://pubmed.ncbi.nlm.nih.gov/32046081/
3. Morales, Paula, Isawi, Israa, Reggio, Patricia H. 2018. Towards a better understanding of the cannabinoid-related orphan receptors GPR3, GPR6, and GPR12. In Drug metabolism reviews, 50, 74-93. doi:10.1080/03602532.2018.1428616. https://pubmed.ncbi.nlm.nih.gov/29390908/
4. Laun, Alyssa S, Song, Zhao-Hui. 2017. GPR3 and GPR6, novel molecular targets for cannabidiol. In Biochemical and biophysical research communications, 490, 17-21. doi:10.1016/j.bbrc.2017.05.165. https://pubmed.ncbi.nlm.nih.gov/28571738/
5. Sun, Huikai, Monenschein, Holger, Schiffer, Hans H, Carlton, Mark Beresford Lewis, Brice, Nicola L. 2021. First-Time Disclosure of CVN424, a Potent and Selective GPR6 Inverse Agonist for the Treatment of Parkinson's Disease: Discovery, Pharmacological Validation, and Identification of a Clinical Candidate. In Journal of medicinal chemistry, 64, 9875-9890. doi:10.1021/acs.jmedchem.0c02081. https://pubmed.ncbi.nlm.nih.gov/33861086/
6. Li, Zejiao, Jiang, Biying, Cao, Baolong, Huang, Yan, Wang, Yajun. 2021. Characterization of Four Orphan Receptors (GPR3, GPR6, GPR12 and GPR12L) in Chickens and Ducks and Regulation of GPR12 Expression in Ovarian Granulosa Cells by Progesterone. In Genes, 12, . doi:10.3390/genes12040489. https://pubmed.ncbi.nlm.nih.gov/33801713/
7. Brice, Nicola L, Schiffer, Hans H, Monenschein, Holger, Hitchcock, Stephen H, Carlton, Mark B. 2021. Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease. In The Journal of pharmacology and experimental therapeutics, 377, 407-416. doi:10.1124/jpet.120.000438. https://pubmed.ncbi.nlm.nih.gov/33795395/